ArticleJournal of clinical and experimental hepatology
Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus Retreatment in Difficult-to-treat Patients: A Real-life Observational Study from India.
Harshita Katiyar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.